The rpl10-R98S mutant blocks both Tif6 and Nmd3 release in vivo, and genetic suppression of this T-ALL associated mutant showed that mutations in Nmd3 restored Tif6 release. This evidence concerns the gene NMD3 and acute lymphoblastic leukemia.